Connected Health and Digital Age of Medicines

Overall, “Connected Health” is a word, which is progressively used to define the new technology-enabled health care delivery framework. To date, there is no standard description for Connected Health, but its definition could encompass terms like digital, wireless, mobile, telehealth, and electronic(Petereit, 2015). As such, it is the conceptual framework for healthcare management in which services, interventions, or devices are developed around the needs of the patients, and health-linked information is shared in a manner that the patients are capable of receiving care most effectively and proactively possible.

Every stakeholder within the process is connected using timely sharing as well as the presentation of pertinent and accurate data regarding the status of the patient through smarter use of information, communication platforms, people, and devices. Therefore, this approach enables people to shift from reactive episodic health frameworks to more proactive models, which link the stakeholders on the spectrum from households to acute care environments all through the lifespan (Petereit, 2015). Additionally, the model puts the clients at the process’ center, and in doing so, it features the potential of empowering clinicians, healthcare planners, and patients alike through the delivery of pertinent data at the critical touch-points.

For instance, some of the common innovations that help oncologists in providing effective treatments towards cancer patients include the GPS Cancer™ and Liquid GPS. The GPS Cancer™ is a first of its kind technology innovation that connects patients, providers, and insurers across the care continuum. Its main objectives include: Provision of the molecular profile, FDA approved therapies, and the Integration of genome sequencing(Petereit, 2015). On the one side, Liquid GPS is a blood-based molecular technology assessment that offers powerful insights to oncologists for profiling of noninvasive tumors. Subsequently, the evaluation also considers quantitative regulations of every treatment response. As such, Liquid GPS provides molecular insights into fundamental policy based biomarkers like ROS1, KRAS, ALK, and EGFR.


Petereit, D. G. (2015). Global Challenges in Radiation Oncology. S.L: Frontiers Media SA.

Do you need high quality Custom Essay Writing Services?

Custom Essay writing Service